12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga_article·Sep 14, 2026 at 09:06 PMBGMS-1.32%RADX-10.56%
Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovationprnewswire·Sep 9, 2026 at 11:30 AMGLMD0.00%EOCN-4.43%
Galmed regains Nasdaq compliance with $1 minimum bid price rulePUBT·Sep 8, 2026 at 10:09 AMGLMD0.00%EOCN-4.43%
Galmed Pharmaceuticals Shareholders Approve All Proposals at September 3 AGMTip Ranks·Sep 3, 2026 at 11:30 PMGLMD0.00%EOCN-4.43%
Galmed Pharmaceuticals holds annual shareholder meetingPUBT·Sep 3, 2026 at 08:10 PMGLMD0.00%EOCN-4.43%
Galmed Pharmaceuticals Posts Higher R&D Spend and Shrinking Cash in Q2 2026Tip Ranks·Sep 2, 2026 at 09:18 PMGLMD0.00%EOCN-4.43%
Galmed Pharmaceuticals effects 1-for-8 reverse stock splitPUBT·Sep 2, 2026 at 08:21 PMGLMD0.00%EOCN-4.43%
Galmed adjourns annual shareholder meeting to Sept. 3 after lack of quorumPUBT·Sep 2, 2026 at 08:07 PMGLMD0.00%EOCN-4.43%
SPAC Mergers, Biotech Trials, and Supply Chain Shifts Reshape the Fringe MarketGlobal Report·Aug 27, 2026 at 10:13 AMGLMD0.00%EOCN-4.43%
Galmed amends AGM proxy materials ahead of Sept. 2 shareholder votePUBT·Aug 19, 2026 at 08:06 PMGLMD0.00%EOCN-4.43%
Galmed says Colospan intraoperative colon tissue assessment study meets feasibility goal in first-in-human trialPUBT·Aug 19, 2026 at 11:00 AMGLMD0.00%EOCN-4.43%
Galmed Announces First Time Results in Prostate Oncology Studies: Aramchol Demonstrates 3-4 Fold Increase in Cell Death Compared to Enzalutamide (XTANDI®) Alone in Prostate Cancer Models | GLMD Stock NewsStockTitan·Aug 17, 2026 at 05:15 AMGLMD0.00%EOCN-4.43%
